PL1905775T3 - Związki tetracyliczne, sposób ich wytwarzania, zawierające je kompozycje farmaceutyczne i ich zastosowanie jako ligandy receptorów dopaminergicznych - Google Patents

Związki tetracyliczne, sposób ich wytwarzania, zawierające je kompozycje farmaceutyczne i ich zastosowanie jako ligandy receptorów dopaminergicznych

Info

Publication number: PL1905775T3
Authority: PL; Poland
Prior art keywords: preparing; pharmaceutical compositions; compositions containing; dopamine receptors; tetracyclic compounds
Prior art date: 2006-09-26

Application number

PL07291135T

Other languages

English (en)

Inventor

Jean-Louis Peglion

Christophe Poitevin

Mark Millan

Mauricette Brocco

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-09-26

Filing date

2007-09-25

Publication date

2011-03-31

2007-09-25 Application filed by Servier Lab filed Critical Servier Lab

2011-03-31 Publication of PL1905775T3 publication Critical patent/PL1905775T3/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Reproductive Health (AREA)
Psychiatry (AREA)
Vascular Medicine (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Cardiology (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Gynecology & Obstetrics (AREA)
Epidemiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

PL07291135T 2006-09-26 2007-09-25 Związki tetracyliczne, sposób ich wytwarzania, zawierające je kompozycje farmaceutyczne i ich zastosowanie jako ligandy receptorów dopaminergicznych PL1905775T3 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0608413A FR2906249B1 (fr)	2006-09-26	2006-09-26	Composes tetracycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP07291135A EP1905775B1 (fr)	2006-09-26	2007-09-25	Composés tétracycliques, leur procédé de préparation, les compositions pharmaceutiques qui les contiennent et leur utilisation comme ligands des récepteurs dopaminergiques.

Publications (1)

Publication Number	Publication Date
PL1905775T3 true PL1905775T3 (pl)	2011-03-31

Family

ID=37877016

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL07291135T PL1905775T3 (pl)	2006-09-26	2007-09-25	Związki tetracyliczne, sposób ich wytwarzania, zawierające je kompozycje farmaceutyczne i ich zastosowanie jako ligandy receptorów dopaminergicznych

Country Status (31)

Country	Link
US (1)	US7470683B2 (pl)
EP (1)	EP1905775B1 (pl)
JP (1)	JP2008100995A (pl)
KR (1)	KR100934315B1 (pl)
CN (1)	CN101153043B (pl)
AR (1)	AR062950A1 (pl)
AT (1)	ATE480544T1 (pl)
AU (1)	AU2007219281A1 (pl)
BR (1)	BRPI0703655A2 (pl)
CA (1)	CA2603274C (pl)
CY (1)	CY1110799T1 (pl)
DE (1)	DE602007009004D1 (pl)
DK (1)	DK1905775T3 (pl)
EA (1)	EA013406B1 (pl)
ES (1)	ES2351945T3 (pl)
FR (1)	FR2906249B1 (pl)
GE (1)	GEP20104877B (pl)
HR (1)	HRP20100605T1 (pl)
MA (1)	MA29371B1 (pl)
MX (1)	MX2007011524A (pl)
MY (1)	MY142517A (pl)
NO (1)	NO20074889L (pl)
NZ (1)	NZ561905A (pl)
PL (1)	PL1905775T3 (pl)
PT (1)	PT1905775E (pl)
RS (1)	RS51418B (pl)
SG (1)	SG141382A1 (pl)
SI (1)	SI1905775T1 (pl)
UA (1)	UA96125C2 (pl)
WO (1)	WO2008037888A2 (pl)
ZA (1)	ZA200708215B (pl)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4420480A (en) *	1981-11-20	1983-12-13	Merck & Co., Inc.	Hexahydronaphth[1,2-b]-1,4-oxazines
CA1204745A (en) *	1981-11-20	1986-05-20	Merck Co.	Hexahydronaphth (1,2-b) -1,4 -oxazines
FR2721027B1 (fr)	1994-06-08	1996-07-19	Adir	Nouveaux dérivés tétracycliques de la 1,4-oxazine, leur procédé de préparation et les compositions pharmaceutiques les contenant.
FR2741074B1 (fr)	1995-11-09	1997-12-19	Adir	Nouveaux composes tetracycliques de la 1,4-oxazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2767825A1 (fr) *	1997-09-01	1999-02-26	Adir	Nouvelles trans-3,4,4a,5,6,10b-hexahydro-2h-napht°1,2-b!-1, 4-oxazines disubstituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2845994B1 (fr) *	2002-10-18	2006-05-19	Servier Lab	Nouveaux derives de benzo[e][1,4]oxazino[3,2-g]isoindole substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

2006
- 2006-09-26 FR FR0608413A patent/FR2906249B1/fr not_active Expired - Fee Related
2007
- 2007-09-11 MA MA30219A patent/MA29371B1/fr unknown
- 2007-09-19 MX MX2007011524A patent/MX2007011524A/es unknown
- 2007-09-21 KR KR1020070096525A patent/KR100934315B1/ko not_active Expired - Fee Related
- 2007-09-24 EA EA200701807A patent/EA013406B1/ru not_active IP Right Cessation
- 2007-09-24 CN CN2007101617348A patent/CN101153043B/zh not_active Expired - Fee Related
- 2007-09-24 AU AU2007219281A patent/AU2007219281A1/en not_active Abandoned
- 2007-09-24 SG SG200708582-2A patent/SG141382A1/en unknown
- 2007-09-24 AR ARP070104197A patent/AR062950A1/es unknown
- 2007-09-25 DK DK07291135.7T patent/DK1905775T3/da active
- 2007-09-25 ES ES07291135T patent/ES2351945T3/es active Active
- 2007-09-25 PL PL07291135T patent/PL1905775T3/pl unknown
- 2007-09-25 NZ NZ561905A patent/NZ561905A/en not_active IP Right Cessation
- 2007-09-25 GE GEAP200710284A patent/GEP20104877B/en unknown
- 2007-09-25 DE DE602007009004T patent/DE602007009004D1/de active Active
- 2007-09-25 EP EP07291135A patent/EP1905775B1/fr active Active
- 2007-09-25 RS RSP-2010/0420A patent/RS51418B/sr unknown
- 2007-09-25 WO PCT/FR2007/001557 patent/WO2008037888A2/fr not_active Ceased
- 2007-09-25 MY MYPI20071605A patent/MY142517A/en unknown
- 2007-09-25 AT AT07291135T patent/ATE480544T1/de active
- 2007-09-25 SI SI200730350T patent/SI1905775T1/sl unknown
- 2007-09-25 PT PT07291135T patent/PT1905775E/pt unknown
- 2007-09-25 US US11/904,006 patent/US7470683B2/en not_active Expired - Fee Related
- 2007-09-26 ZA ZA200708215A patent/ZA200708215B/xx unknown
- 2007-09-26 NO NO20074889A patent/NO20074889L/no not_active Application Discontinuation
- 2007-09-26 UA UAA200710656A patent/UA96125C2/ru unknown
- 2007-09-26 CA CA2603274A patent/CA2603274C/fr not_active Expired - Fee Related
- 2007-09-26 JP JP2007248428A patent/JP2008100995A/ja not_active Ceased
- 2007-09-26 BR BRPI0703655-8A patent/BRPI0703655A2/pt not_active IP Right Cessation
2010
- 2010-09-24 CY CY20101100862T patent/CY1110799T1/el unknown
- 2010-11-10 HR HR20100605T patent/HRP20100605T1/hr unknown

Also Published As

Publication number	Publication date
PT1905775E (pt)	2010-11-17
ES2351945T3 (es)	2011-02-14
FR2906249A1 (fr)	2008-03-28
SG141382A1 (en)	2008-04-28
ZA200708215B (en)	2008-09-25
CN101153043B (zh)	2011-01-19
BRPI0703655A2 (pt)	2009-05-19
EA013406B1 (ru)	2010-04-30
GEP20104877B (en)	2010-01-11
HK1119163A1 (en)	2009-02-27
US7470683B2 (en)	2008-12-30
DK1905775T3 (da)	2010-12-06
FR2906249B1 (fr)	2008-12-19
MA29371B1 (fr)	2008-04-01
UA96125C2 (ru)	2011-10-10
WO2008037888A3 (fr)	2008-06-12
DE602007009004D1 (de)	2010-10-21
SI1905775T1 (sl)	2010-10-29
EP1905775A1 (fr)	2008-04-02
HRP20100605T1 (hr)	2010-12-31
KR20080028316A (ko)	2008-03-31
NO20074889L (no)	2008-03-27
NZ561905A (en)	2009-01-31
EP1905775B1 (fr)	2010-09-08
MY142517A (en)	2010-12-15
EA200701807A1 (ru)	2008-04-28
CA2603274C (fr)	2010-08-31
AR062950A1 (es)	2008-12-17
CA2603274A1 (fr)	2008-03-26
US20080076765A1 (en)	2008-03-27
AU2007219281A1 (en)	2008-04-10
KR100934315B1 (ko)	2009-12-29
MX2007011524A (es)	2009-02-16
WO2008037888A2 (fr)	2008-04-03
ATE480544T1 (de)	2010-09-15
CY1110799T1 (el)	2015-06-10
JP2008100995A (ja)	2008-05-01
RS51418B (sr)	2011-02-28
CN101153043A (zh)	2008-04-02

Publication	Publication Date	Title
IL196280A0 (en)	2009-09-22	Use of ampk-activating imidazole derivatives, preparation process therefor and pharmaceutical compositions comprising them
IL200854A (en)	2014-02-27	Converted Spiro Compounds, Methods for their Preparation and Pharmaceutical Compositions Containing Them to Delay New Vascular Formation
EP2184064A4 (en)	2010-05-12	5-HT6 RECEPTOR LIGAND, PHARMACEUTICAL COMPOSITION AND METHOD OF MANUFACTURE AND USE
AP2975A (en)	2014-09-30	Pharmaceutical formulations containing dopamine receptor ligands
IL208832A0 (en)	2011-01-31	3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor
IL203142A (en)	2015-02-26	Anti-B antibody CD79, pharmaceuticals including them, their use and method of preparation
PT2185155T (pt)	2018-01-04	Composições farmacêuticas que contêm ligantes recetores de dopamina e métodos de tratamento com a utilização de ligantes recetores de dopamina
AP3024A (en)	2014-11-30	New Diosmetin compounds, a process for their preparation and pharmaceutical compositions containing them
IL207356A0 (en)	2010-12-30	5, 6 - bisaryl-2- pyridine - carboxamide derivatives, preparation thereof and therapeutic application thereof as antagonists for urotensine ii receptors
PL1953161T3 (pl)	2010-01-29	Nowe tricykliczne pochodne, sposób ich wytwarzania i kompozycje farmaceutyczne zawierające te pochodne
IL218525A (en)	2014-12-31	Compounds 2,1 - Dihydro - 2 - Oxoquinoline Receptor Legendants 5 - 4ht Process for Preparing, Containing and Using Medical Preparations
IL221244A0 (en)	2012-10-31	Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it
HUP0600809A2 (en)	2008-08-28	New phenylsulfamoyl-benzamide derivatives as bradykinin antagonists, process and intermediates for their preparation and pharmaceutical compositions containing them
SI2147915T1 (sl)	2010-11-30	Novi cikloalkilirani benzotiadiazinski derivati postopek za njihovo pripravo in farmacevtski sestavki ki jih vsebujejo
HUP0600808A3 (en)	2008-09-29	New benzamide derivatives as bradykinin antagonists, process for their preparation and pharmaceutical compositions containing them
IL198634A0 (en)	2010-02-17	Novel compounds, pharmaceutical compositions containing same, and methods of use for same
PL1873140T3 (pl)	2010-01-29	Nowe pochodne naftalenowe, sposób ich wytwarzania i kompozycje farmaceutyczne je zawierające
PL1905775T3 (pl)	2011-03-31	Związki tetracyliczne, sposób ich wytwarzania, zawierające je kompozycje farmaceutyczne i ich zastosowanie jako ligandy receptorów dopaminergicznych
AP2009004891A0 (en)	2009-06-30	New azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them
HUP0600847A3 (en)	2010-05-28	Chiral betha aminoacids and their derivatives, process for their preparation pharmaceutical compositions containing the same and use of the compounds